Hajnalka Hejja

Hajnalka Hejja, MD has an extensive background in the medical field. Hajnalka'smost recent role was as the Head of Surveillance & Clinical Affairs at Clue by Biowink. In this position, they oversaw the Quality & Regulatory department, led the self-certification process for the Clue app, and was responsible for surveillance activities and reporting on the company's quality and clinical performance. Hajnalka also supported research and product partnerships with biopharmaceuticals. Prior to that, they served as the Sr. Medical Safety Lead and as the Science Lead for Product at Clue by Biowink.

Before joining Clue, Hajnalka worked as an Independent Evaluator for the European Commission and as the CEO & Founder of Super Izzy AI, where they focused on reproductive health issues and created a virtual assistant with AI technology. Hajnalka also held various roles at Tata Consultancy Services - AstraZeneca, including Lead Physician for Medical Review - Infection, Medical Reviewer and Trainer, and Medical Advisor. In these positions, they were responsible for medical review, pharmacovigilance, and serving as a point of contact for medical queries.

Hajnalka's early career included a role as the Marketing Manager at Omixon Biocomputing, where they worked on molecular diagnostics and genotyping products.

Throughout their career, Hajnalka has demonstrated expertise in medical safety, regulatory compliance, and product development, making their a valuable asset in the healthcare industry.

Hajnalka Hejja, MD earned a Doctor of Philosophy (PhD) degree in Oxidative Stress in Preeclampsia from Semmelweis University between 2013 and 2016. Prior to that, they completed a Clinical Biotechnology program at Semmelweis University from 2012 to 2013. Hajnalka also holds a Doctor of Medicine (MD) degree in General Medicine from Semmelweis University, which they obtained between 2006 and 2012.